TCEPX
Price
$40.09
Change
-$0.10 (-0.25%)
Updated
Sep 20 closing price
VSMPX
Price
$256.96
Change
-$0.63 (-0.24%)
Updated
Sep 20 closing price
Ad is loading...

TCEPX vs VSMPX

Header iconTCEPX vs VSMPX Comparison
Open Charts TCEPX vs VSMPXBanner chart's image
Nuveen Equity Index Premier
Price$40.09
Change-$0.10 (-0.25%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Pls
Price$256.96
Change-$0.63 (-0.24%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TCEPX vs VSMPX Comparison Chart
Loading...
VS
TCEPX vs. VSMPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCEPX is a Buy and VSMPX is a Buy.

FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.72T vs. TCEPX (48B). VSMPX pays higher dividends than TCEPX: VSMPX (1.36) vs TCEPX (1.18). TCEPX was incepted earlier than VSMPX: TCEPX (15 years) vs VSMPX (9 years). TCEPX is a more actively managed with annual turnover of: 7.00 vs. VSMPX (2.00). TCEPX has a lower initial minimum investment than VSMPX: TCEPX (0) vs VSMPX (100000000). TCEPX annual gain was more profitable for investors over the last year : 27.38 vs. VSMPX (25.90). TCEPX return over 5 years is better than : 90.37 vs. VSMPX (83.02).
TCEPXVSMPXTCEPX / VSMPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years9 years-
Gain YTD17.55416.929104%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets48B1.72T3%
Annual Yield % from dividends1.181.3687%
Returns for 1 year27.3825.90106%
Returns for 3 years23.6421.36111%
Returns for 5 years90.3783.02109%
Returns for 10 years173.77N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRZA0.320.03
+12.01%
Forza X1
EVER22.26-0.02
-0.09%
EverQuote
RPRX28.21-0.03
-0.11%
Royalty Pharma plc
ATMU35.61-0.26
-0.72%
Atmus Filtration Technologies
OTLK5.93-0.11
-1.82%
Outlook Therapeutics